234 related articles for article (PubMed ID: 24565479)
1. Update on immune mechanisms associated with sublingual immunotherapy: practical implications for the clinician.
Moingeon P
J Allergy Clin Immunol Pract; 2013; 1(3):228-41. PubMed ID: 24565479
[TBL] [Abstract][Full Text] [Related]
2. Sublingual allergen immunotherapy: mode of action and its relationship with the safety profile.
Calderón MA; Simons FE; Malling HJ; Lockey RF; Moingeon P; Demoly P
Allergy; 2012 Mar; 67(3):302-11. PubMed ID: 22150126
[TBL] [Abstract][Full Text] [Related]
3. Characterization of oral immune cells in birch pollen-allergic patients: impact of the oral allergy syndrome and sublingual allergen immunotherapy on antigen-presenting cells.
Mascarell L; Rak S; Worm M; Melac M; Soulie S; Lescaille G; Lemoine F; Jospin F; Paul S; Caplier L; Hasséus B; Björhn C; Zeldin RK; Baron-Bodo V; Moingeon P
Allergy; 2015 Apr; 70(4):408-19. PubMed ID: 25631199
[TBL] [Abstract][Full Text] [Related]
4. Grass tablet sublingual immunotherapy downregulates the TH2 cytokine response followed by regulatory T-cell generation.
Suárez-Fueyo A; Ramos T; Galán A; Jimeno L; Wurtzen PA; Marin A; de Frutos C; Blanco C; Carrera AC; Barber D; Varona R
J Allergy Clin Immunol; 2014 Jan; 133(1):130-8.e1-2. PubMed ID: 24290282
[TBL] [Abstract][Full Text] [Related]
5. Immune mechanisms of allergen-specific sublingual immunotherapy.
Moingeon P; Batard T; Fadel R; Frati F; Sieber J; Van Overtvelt L
Allergy; 2006 Feb; 61(2):151-65. PubMed ID: 16409190
[TBL] [Abstract][Full Text] [Related]
6. Repeated antigen painting and sublingual immunotherapy in mice convert sublingual dendritic cell subsets.
Zhang C; Ohno T; Kang S; Takai T; Azuma M
Vaccine; 2014 Sep; 32(43):5669-76. PubMed ID: 25168308
[TBL] [Abstract][Full Text] [Related]
7. Immunological mechanisms of sublingual immunotherapy.
Akdis CA; Barlan IB; Bahceciler N; Akdis M
Allergy; 2006; 61 Suppl 81():11-4. PubMed ID: 16792600
[TBL] [Abstract][Full Text] [Related]
8. Mapping of the lingual immune system reveals the presence of both regulatory and effector CD4+ T cells.
Mascarell L; Lombardi V; Zimmer A; Louise A; Tourdot S; Van Overtvelt L; Moingeon P
Clin Exp Allergy; 2009 Dec; 39(12):1910-9. PubMed ID: 19694757
[TBL] [Abstract][Full Text] [Related]
9. Induction of tolerance via the sublingual route: mechanisms and applications.
Moingeon P; Mascarell L
Clin Dev Immunol; 2012; 2012():623474. PubMed ID: 22110534
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms underlying the induction of regulatory T cells by sublingual immunotherapy.
Tanaka Y; Fukumoto S; Sugawara S
J Oral Biosci; 2019 Jun; 61(2):73-77. PubMed ID: 31109864
[TBL] [Abstract][Full Text] [Related]
11. Immune mechanisms of sublingual immunotherapy.
Jay DC; Nadeau KC
Curr Allergy Asthma Rep; 2014 Nov; 14(11):473. PubMed ID: 25195100
[TBL] [Abstract][Full Text] [Related]
12. Differences and similarities between sublingual immunotherapy of allergy and oral tolerance.
Moingeon P; Mascarell L
Semin Immunol; 2017 Apr; 30():52-60. PubMed ID: 28760498
[TBL] [Abstract][Full Text] [Related]
13. Dendritic cells as potential targets for mucosal immunotherapy.
Allam JP; Bieber T; Novak N
Curr Opin Allergy Clin Immunol; 2009 Dec; 9(6):554-7. PubMed ID: 19745726
[TBL] [Abstract][Full Text] [Related]
14. Subcutaneous versus sublingual immunotherapy for allergic rhinitis and/or asthma.
Bahceciler NN; Cobanoglu N
Immunotherapy; 2011 Jun; 3(6):747-56. PubMed ID: 21668312
[TBL] [Abstract][Full Text] [Related]
15. Effect of sublingual immunotherapy with grass monomeric allergoid on allergen-specific T-cell proliferation and interleukin 10 production.
Burastero SE; Mistrello G; Falagiani P; Paolucci C; Breda D; Roncarolo D; Zanotta S; Monasterolo G; Rossi RE
Ann Allergy Asthma Immunol; 2008 Apr; 100(4):343-50. PubMed ID: 18450120
[TBL] [Abstract][Full Text] [Related]
16. Immunological mechanisms of sublingual allergen-specific immunotherapy.
Novak N; Bieber T; Allam JP
Allergy; 2011 Jun; 66(6):733-9. PubMed ID: 21251016
[TBL] [Abstract][Full Text] [Related]
17. Lack of detectable alterations in immune responses during sublingual immunotherapy in children with seasonal allergic rhinoconjunctivitis to grass pollen.
Rolinck-Werninghaus C; Kopp M; Liebke C; Lange J; Wahn U; Niggemann B
Int Arch Allergy Immunol; 2005 Feb; 136(2):134-41. PubMed ID: 15650310
[TBL] [Abstract][Full Text] [Related]
18. Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation.
Bohle B; Kinaciyan T; Gerstmayr M; Radakovics A; Jahn-Schmid B; Ebner C
J Allergy Clin Immunol; 2007 Sep; 120(3):707-13. PubMed ID: 17681368
[TBL] [Abstract][Full Text] [Related]
19. Changes in basophil activation during grass-pollen sublingual immunotherapy do not correlate with clinical efficacy.
Van Overtvelt L; Baron-Bodo V; Horiot S; Moussu H; Ricarte C; Horak F; Zieglmayer P; Zieglmayer R; Montagut A; Galvain S; de Beaumont O; Le Gall M; Moingeon P
Allergy; 2011 Dec; 66(12):1530-7. PubMed ID: 21883279
[TBL] [Abstract][Full Text] [Related]
20. Enhancing Allergen-Presentation Platforms for Sublingual Immunotherapy.
Moingeon P; Lombardi V; Baron-Bodo V; Mascarell L
J Allergy Clin Immunol Pract; 2017; 5(1):23-31. PubMed ID: 28065340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
